# Pizarra — PT-pseudo_4a4fedfc1f51 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_4a4fedfc1f51
Task: 1

Encounter: Urology - outpatient on 16 Feb 2025.
Referrer: Dr. M. Jansen (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 56-year-old male
  - PSA: 8.5 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.368 ng/mL²
  - PSA velocity: 2.14 ng/mL/yr
  - Prior PSA: 6.6 ng/mL
  - Prostate volume: 23.08 mL
  - Months since last PSA: 2
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.87014735 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 8.5 ng/mL. PI-RADS 5. PSAD 0.37. Prostate volume 23 mL. DRE nodus. csPCa 0.87.

Vitals: weight 78 kg, height 175 cm, BMI 25.5, BP 118/79 mmHg, HR 81 bpm. Smoking: Ex-smoker (22 pack-yr, quit 2009).

Chief complaint: A marked increase in serum prostate-specific antigen levels alongside concerning multiparametric magnetic resonance imaging results prompted this clinical evaluation.

History: Initial screening in late 2022 uncovered an elevated prostate-specific antigen reading, leading to ongoing serial assessments and symptom monitoring. He is a 56-year-old retired civil servant, widowed, and resides independently in a retirement community. Lower urinary tract complaints are negligible, scoring 5 on the IPSS questionnaire, and his regular cycling routine covers roughly 20 kilometres twice each week. Alcohol consumption averages 24 units weekly. He explicitly denies any urinary retention or haematuria. His medical background is otherwise clear, noting no active medications or systemic comorbidities. Past interventions include a surveillance colonoscopy and occasional over-the-counter analgesics for mild knee discomfort. A recent trip to southern France was documented, and he indicated that an Arabic interpreter would facilitate communication during this consultation.

Physical examination: DRE reveals a discrete Nodus within the left peripheral zone, while the remainder of the gland maintains uniform symmetry. General assessment shows no abnormalities; vital parameters are stable, respiratory sounds remain clear bilaterally, and peripheral lymph nodes are non-palpable.

Patient info: retired civil servant; Widowed; Lives in retirement community (independent unit).
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 24 units / week; exercise Cycling 2x/week, ~20 km; IPSS score: 5/35 (mild LUTS).

Recent other appointments: Gastroenterology — surveillance colonoscopy.
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.83 +/- 0.14   (95% CI 0.47-0.99)

Where the uncertainty comes from:
  - aleatoric  dA = 0.14  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.05  (few labelled cases resemble this one)
  - 4.8 effective neighbours out of 10; 5 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {yes}

TIER 'firm': A +/- 1.96*dA does not cross the 0.5 threshold. On the 91 labelled cases this tier was never wrong, but it only covered 17 of them, so the 95% CI on that accuracy still reaches down to ~0.75. Treat it as a strong prior that should only be overturned by explicit contradicting evidence.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=5.0, bx_ord=0.0, psa=8.5, age=56.0, psad=0.368, dre_ord=1.0, vol=23.08, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GUIDELINE CRITERION FOR THIS SITUATION

**EXPERT-PROTOCOL** — *protocol expert; applies the guideline criterion for this patient's clinical situation*

CLINICAL SITUATION: biopsy-naive.

CRITERION VERDICT: BIOPSY.

The criterion: Biopsy when the mpMRI shows a PI-RADS 3 or higher lesion; defer when PI-RADS is 1-2.

In the labelled cohort this criterion matched the reading urologist in every one of the 24 biopsy-naive cases (20 of them PI-RADS 4-5 and biopsied, 4 of them PI-RADS 2 or unreadable and deferred).

Track record of this criterion on the labelled cohort: 24 of 24 cases matched the reading urologist. Departing from it needs a specific finding from a retrieved document, named explicitly - not a restatement of the panel numbers it already used.

Like the statistical prior, this expert has read ONLY the visible panel. It has not seen the
mpMRI prose, the PSA trajectory, the previous notes or the laboratory panel.

## [4] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
The statistical prior only used the visible panel data (PI-RADS=5.0, PSA=8.5, Age=56.0, PSA density=0.368, DRE=Nodus, Volume=23.08 mL, Prior biopsy=None) and failed to incorporate the PSA velocity (2.14 ng/mL/yr) or the csPCa predicted probability (0.87014735).
WHY THE SUGGESTION COULD BE WRONG
The prior suggested biopsy based on a high probability, but it ignores the potential for overdiagnosis given the high csPCa probability (0.87) and the DRE finding of a Nodus, which might conflict with the high-risk MRI score if the DRE is benign. The prior's uncertainty interval suggests the decision is highly sensitive to unobserved data.
WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
radiology report - does the lesion compare with a previous MRI?
PSA history - trend / velocity beyond the headline value
previous GP / urology notes - context on prior surveillance and symptoms
laboratory panel - full panel
GUIDELINE ANCHOR
The guideline states that a PI-RADS $\ge 3$ is used to trigger biopsy, and MRI-directed biopsy is the standard of care. This constrains the decision by confirming that the PI-RADS 5 score alone is sufficient to warrant consideration for biopsy.

## [5] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
get_mri_report
{"case_id": "PT-pseudo_4a4fedfc1f51", "radiology_report": "PI-RADS 5 lesion in the left mid-gland peripheral zone. Lesion size: 12 x 10 x 9 mm. No extraprostatic extension or seminal vesicle involvement. Radiologist recommends targeted sampling implied by PI-RADS 5."}
get_psa_trend
{"case_id": "PT-pseudo_4a4fedfc1f51", "psa_trend": [{"date": "Sep 2022", "val": 8.1}, {"date": "Dec 2023", "val": 5.6}, {"date": "Feb 2025", "val": 8.5}]}
get_previous_notes
{"case_id": "PT-pseudo_4a4fedfc1f51", "previous_notes": [{"date": "19 Oct 2024", "author": "Dr. M. Jansen (GP)", "text": "A follow-up PSA measurement was arranged for early 2025 to track the ongoing progression."}, {"date": "21 Jun 2024", "author": "Dr. M. Jansen (GP)", "text": "Lower urinary tract complaints remain minimal, reflected by an IPSS score of 5, while his preference for cycling twice weekly continues without issue."}]}
get_lab_results
{"case_id": "PT-pseudo_4a4fedfc1f51", "laboratory_results": [{"name": "PSA", "val": "8.5 ng/mL", "date": "03 Jan 2025", "flag": "H"}, {"name": "Free PSA", "val": "1.52 ng/mL", "date": "03 Jan 2025", "flag": ""}, {"name": "%Free PSA", "val": "18%", "date": "03 Jan 2025", "flag": "L"}]}
NOT RETRIEVED
The pathology report was not retrieved because the task specified that no pathology report exists on file for this decision.
WHAT THE EVIDENCE SUPPORTS
FOR sampling this patient now:
- MRI report: PI-RADS 5 lesion in the left mid-gland peripheral zone (12 x 10 x 9 mm).
- PSA trend: Rising from 5.6 ng/mL (Dec 2023) to 8.5 ng/mL (Feb 2025), with a velocity of 2.14 ng/mL/yr.
- Guideline criterion: PI-RADS $\ge 3$ warrants biopsy.
AGAINST sampling this patient now:
- DRE finding: Nodus (Suspicious/Abnormal finding noted in the initial record).
- Free PSA: 1.52 ng/mL (18% Free PSA).
CONTRADICTION: The high PI-RADS 5 score strongly supports biopsy, despite the DRE finding and the presence of Free PSA.
WHERE THIS LEANS
The evidence strongly points towards proceeding with a biopsy due to the high-risk PI-RADS 5 finding and the concerning PSA velocity. This confirms the statistical prior's suggestion.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [6] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [7] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the PI-RADS 5 score from the MRI report is decisive, aligning with the guideline criterion for biopsy when PI-RADS is 3 or higher. This finding was supported by the rising PSA trend, which showed a velocity of 2.14 ng/mL/yr. The statistical prior and the guideline criterion converged on this decision, and no retrieved evidence contradicted the need for targeted sampling.

Variables that carried weight: age=important, dre=noted, psa=important, vol=noted, psad=important, pirads=decisive, comorbidity=noted
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
